195 filings
Page 5 of 10
8-K
g0i0vt3y5
27 Apr 21
Regulation FD Disclosure
5:01pm
8-K
k2c8l3h ds
8 Apr 21
Provention Bio Provides Regulatory Update on Biologics License Application for Teplizumab
4:05pm
DEFA14A
h1o35o7ahrhlplptg8
29 Mar 21
Additional proxy soliciting materials
4:10pm
PRE 14A
e4ch4463sqh
19 Mar 21
Preliminary proxy
4:20pm
S-8
w33oh ajun
26 Feb 21
Registration of securities for employees
5:22pm
424B5
ovm2p g5e2f
26 Feb 21
Prospectus supplement for primary offering
5:19pm
8-K
hzf27jq
26 Feb 21
Other Events
5:04pm
8-K
eslkoim4
25 Feb 21
Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:21am
8-K
lrt1ty3kavw07h
15 Jan 21
Entry into a Material Definitive Agreement
4:43pm
424B5
kfgufdwzr6arnf d7a
15 Jan 21
Prospectus supplement for primary offering
4:28pm
8-K
ov4lei q1ybideg2
12 Jan 21
Results of Operations and Financial Condition
5:25pm
424B5
mj9vl
12 Jan 21
Prospectus supplement for primary offering
5:16pm
S-3ASR
ej2yuqhlohpn9w8
12 Jan 21
Automatic shelf registration
4:08pm
S-8
ye3bsikrol
5 Nov 20
Registration of securities for employees
4:06pm
8-K
n41zwh iwz4hp
5 Nov 20
Provention Bio Reports Third Quarter 2020 Financial Results and Provides Business Update
7:21am
8-K
zgchg8k3it6re6 qpr
30 Oct 20
Departure of Directors or Certain Officers
4:15pm
UPLOAD
e9an6
24 Aug 20
Letter from SEC
12:00am